Uterine evacuation for second-trimester fetal death and maternal morbidity.
OBJECTIVE
To estimate maternal morbidity associated with uterine evacuation for second-trimester fetal demise compared with that associated with induced second-trimester abortion.


METHODS
This retrospective cohort study compared the maternal outcomes of two cohorts: 1) women diagnosed with fetal demise between 14 and 24 weeks who subsequently underwent dilation and evacuation or induction of labor; and 2) women undergoing induced abortion between 14 and 24 weeks by either dilation and evacuation or induction of labor. The primary outcome was major maternal morbidity. Assuming morbidity rates of 11% for fetal demise and 1% for induced second-trimester abortion, 94 patients were needed per group to detect significant difference in maternal morbidity (80% power, 5% alpha).


RESULTS
We identified 121 women with fetal demise and 121 women who underwent induced abortion for inclusion. There were no maternal deaths. In crude and adjusted analyses, treatment for fetal demise was not associated with increased maternal morbidity (25 of 121) compared with induced abortion (27 of 121) (adjusted odds ratio [OR], 1.15; 95% confidence interval [CI], 0.57-2.32). There were more blood transfusions in the fetal demise group (N=7) compared with the induced-abortion group (N=1) (P=.07). Induction of labor was more morbid than dilation and evacuation after adjusting for confounders (OR 5.36; 95% CI 2.46-11.69), primarily as a result of increased odds of infection requiring intravenous antibiotics. Gestational age of 20 weeks or greater was significantly associated with maternal morbidity (OR 2.59; 95% CI 1.39-4.84).


CONCLUSIONS
In the second trimester, uterine evacuation for fetal demise was not significantly associated with maternal morbidity compared with induced abortion. Induction of labor was more morbid than dilation and evacuation as a result of an increased risk of presumed infection.


METHODS
II.
From the Departments of Obstetrics and Gynecology and Radiology and the Center for Clinical Investigation, Brigham and Women's Hospital, Boston, Massachusetts; the Department of Obstetrics and Gynecology, Boston Medical Center, Boston, Massachusetts; and Women's Health Services, Brookline, Massachusetts.
Andrea G
AG
Edlow
Melody Y
MY
Hou
Rie
R
Maurer
Carol
C
Benson
Laurent
L
Delli-Bovi
Alisa B
AB
Goldberg
D000028:Abortion, Induced / Q000009:adverse effects*; D000328:Adult; D005260:Female; D005313:Fetal Death / Q000628:therapy*; D006801:Humans; D007751:Labor, Induced / Q000009:adverse effects*; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D012189:Retrospective Studies; D014619:Vacuum Curettage / Q000009:adverse effects*; D055815:Young Adult
Pritchard JA. Fetal death in utero. Obstet Gynecol 1959;14:573–80.
Pritchard JA. Hematological problems associated with delivery, placental abruption, retained dead fetus and amniotic fluid embolism. Clin Hematol 1973;2:563–86.
Tricomi V, Kohl SG. [Fetal death in utero.] Am J Obstet Gynecol 1957;74:1092–7.
Magann EF, Chauhan SP, Bofill JA, Waddell D, Rust OA, Morrison JC. Maternal morbidity and mortality associated with intrauterine fetal demise: five-year experience in a tertiary referral hospital. South Med J 2001;94:493–5.
Maslow AD, Breen TW, Sarna MC, Soni AK, Watkins J, Oriol NE. Prevalence of coagulation abnormalities associated with intrauterine fetal death. Can J Anaesth 1996;43:1237–43.
Tempfer CB, Brunner A, Bentz EK, Langer M, Reinthaller A, Hefler LA. Intrauterine fetal death and delivery complications associated with coagulopathy: a retrospective analysis of 104 cases. J Womens Health (Larchmt) 2009;18:469–74.
Ifnan F, Jameel MB. Maternal morbidity and mortality associated with delivery after intrauterine fetal death. J Coll Physicians Surg Pak 2006;16:648–51.
Grimes DA. Estimation of pregnancy-related mortality risk by pregnancy outcome, United States, 1991 to 1999. Am J Obstet Gynecol 2006;194:92–4.
Grimes DA, Smith MS, Witham AD. Mifepristone and misoprostol versus dilation and evacuation for midtrimester abortion: a pilot randomised controlled trial. BJOG 2004;111:148–53.
Turok DK, Gurtcheff SE, Esplin MS, Shah M, Simonsen SE, Trauscht-Van Horn J, et al. Second trimester termination of pregnancy: a review by site and procedure type. Contraception 2008;77:155–61.
Autry AM, Hayes EC, Jacobson GF, Kirby RS. A comparison of medical induction and dilation and evacuation for second-trimester abortion. Am J Obstet Gynecol 2002;187:393–7.
Benson CB, Doubilet PM. Sonographic prediction of gestational age: accuracy of second- and third-trimester fetal measurements. AJR Am J Roentgenol 1991;157:1275–7.
Allison PD. Missing data. Thousand Oaks (CA): Sage; 2001.
Calderon-Margalit R, Friedlander Y, Yanetz R, Deutsch L, Manor O, Harlap S, et al. Late stillbirths and long-term mortality of mothers. Obstet Gynecol 2007;109:1301–8.